BIVI
BioVie·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 1
Ample Liquidity
RSI Oversold
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About BIVI
Biovie Inc.
A clinical-stage biopharmaceutical company developing innovative treatments for neurological and psychiatric disorders
680 W Nye Lane Suite 204, Carson City, NV 89703
--
BioVie Inc., founded on April 10, 2013, is a Nevada corporation. The company is a clinical-stage company dedicated to the development of innovative drug therapies to treat chronic debilitating diseases, including neurological and neurodegenerative diseases and liver diseases.
Company Financials
EPS
BIVI has released its 2024 Q2 earnings. EPS was reported at -0.22, versus the expected -0.32, beating expectations. The chart below visualizes how BIVI has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
